Trial reportPain research & management2026
Effects of Acupoint Application on Lower Urinary Tract Symptoms in Patients Undergoing Intravesical Instillation After Bladder Cancer Surgery: A Randomized Crossover Exploratory Study.
Trial report in Pain research & management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectivePatients with non-muscle-invasive bladder cancer (NMIBC) often experience lower urinary tract symptoms (LUTS) after postoperative intravesical instillation, impairing quality of life and treatment adherence. This study explored the effects of traditional Chinese medicine (TCM) acupoint application on postinstillation LUTS and quality of life.
methodsIn this randomized, single-blind, crossover exploratory study, patients receiving postoperative intravesical instillation alternately underwent conventional instillation or instillation following TCM acupoint application, separated by a 1-week washout period. Primary outcomes included visual analog scale (VAS) scores and 24-h voiding diary parameters. Secondary outcomes included EORTC QLQ-C30 and FACT scores. The outcome measures were analyzed using linear mixed-effects model (LMM).
resultsLMM analysis showed that, compared with conventional intravesical instillation, acupoint application was associated with significant reductions in the total number of voiding episodes within 24 h, daytime voiding frequency, episodes of urinary urgency, and episodes of dysuria following intravesical instillation (all p < 0.05). VAS scores and nocturnal voiding frequency also showed decreasing trends, although the differences were not statistically significant (p > 0.05). Compared with conventional intravesical instillation, acupoint application resulted in a significant improvement in the physical functioning score of the EORTC QLQ-C30 (p < 0.05). Improvements were also observed in global health status and the role, emotional, cognitive, and social functioning domains; however, these differences did not reach statistical significance (p > 0.05). With respect to the symptom domains, scores for fatigue, pain, insomnia, and appetite loss also showed trends toward improvement after acupoint application, but the differences were not statistically significant (p > 0.05). No statistically significant differences were observed in any functional domain of the FACT scale between acupoint application and conventional intravesical instillation (p > 0.05).
conclusionThis exploratory study provides preliminary evidence that TCM acupoint application may have the potential to alleviate LUTS in patients after surgery for bladder cancer, while also showing a trend toward improving patients' quality of life. These findings provide preliminary evidence to support the feasibility of subsequent studies, optimization of study design, and estimation of sample size for future trials.
trial registrationChinese Clinical Trial Registry: ChiCTR2300074736.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.